# Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism

> **NCT01786473** · PHASE3 · UNKNOWN · sponsor: **Laboratoires Besins International** · enrollment: 240 (estimated)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Testogel 1%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01786473
- **Lead sponsor:** Laboratoires Besins International
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2013-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01786473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01786473, "Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism". Retrieved via AI Analytics 2026-08-21 from https://api.ai-analytics.org/clinical/NCT01786473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*